The Rising threat of Invasive fungal infections

Authors

  • Anant Marathe Head, Department of Microbiology, Parul Institute of Medical Sciences & Research, Parul, University, Vadodara, Gujarat, India.

Abstract

Fungi are ubiquitous. Fungal Infections have been known for decades. Superficial fungal infections are common in tropical countries. Over the last two decades, there has been a constant increase in the burden of fungal infections worldwide and in India. Over 300 million people worldwide are affected by invasive fungal Infections. Most of the patients have one or more co-existing conditions. Although some fungal infections are endemic to particular geographical areas, most fungal infections depend on multiple risk factors.

References

. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, and White TC Hidden killers: human fungal infections Sci Transl Med 2012; 4:165rv13.

. Ray A, Aayilliath K A, Banerjee S, Chakrabarti A, and Denning DW Burden of Serious fungus Infections in India. Open Forum Infect Dis. 2022 Dec 26;9(12):ofac603. doi: 10.1093/ofid/ofac603. PMID: 36589484; PMCID: PMC9792086.

. Muskett H., Shahin J., Eyres G., Harvey S., Rowan K., and Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review Crit Care. 2011;15(6):R287. doi: 10.1186/cc10574. Epub 2011 Nov 29. PMID: 22126425; PMCID: PMC3388661.

. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Et al.; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis. 2008 Jun 15;46(12):1813–21. doi: 10.1086/588660. PMID: 18462102; PMCID: PMC2671227.

. Arastehfar A, Gabaldón T, Garcia-Rubio R, Jenks JD, Hoenigl M, Salzer HJF, Ilkit M, Lass-Flörl C, Perlin DS Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium Antibiotics (Basel). 2020 Dec 8;9(12):877. doi: 10.3390/antibiotics9120877. PMID: 33302565; PMCID: PMC7764418.

. Arastehfar A, Daneshnia F, Salehi M, Yaşar M, Hoşbul T, Ilkit M, Pan W, Hagen F, Arslan N, Türk-Da H, Hilmiolu-Polat S, Perlin DS, Lass-Flörl C. Low levels of antifungal resistance in Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure. Mycoses. 2020 Sep;63(9):911–920. doi: 10.1111/myc.13104. Epub 2020 Aug 5. PMID: 32413170; PMCID: PMC7497236.

. Diagnosis and Management of Invasive Fungal Infections in a Critical Care Setting Amit Aggarwal, MPS Chawla, JIACM 2021; 22 (3–4):117–32.

Published

2023-08-01

How to Cite

Marathe, A. (2023). The Rising threat of Invasive fungal infections. Parul University Journal of Health Sciences and Research, 2(1), 1–3. Retrieved from https://pujhsr.paruluniversity.ac.in/index.php/home/article/view/22

Issue

Section

Editorial